期刊
LIGHTING RESEARCH & TECHNOLOGY
卷 47, 期 2, 页码 161-176出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1477153513517255
关键词
-
资金
- National Institutes of Health/National Center for Complementary and Alternative Medicine [R21 AT004500-01A1]
- National Institute on Aging [R01 AG34157]
Sleep disorders are problematic for persons with dementia and their family caregivers. This randomized controlled trial with crossover evaluated the effects of an innovative blue-white light therapy on 17 pairs of home-dwelling persons with dementia and their caregivers. Subjects with dementia received blue-white light and control (red-yellow' light) for six weeks separated by a four-week washout. Neither actigraphic nor most self-reported sleep measures significantly differed for subjects with dementia. For caregivers, both sleep and role strain improved. No evidence of retinal light toxicity was observed. Six weeks of modest doses of blue-white light appear to improve sleep in caregivers but not in persons with dementia. Greater or prolonged circadian stimulation may be needed to determine if light is an effective treatment for persons with dementia.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据